Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1047 of 5804
-
How much eye surgery is best for babies with glaucoma?
Disease control Not yet recruitingBrief Summary This is a multicenter cohort study designed to evaluate and compare the efficacy and safety of different surgical extents of goniotomy (GT) - specifically 120°, 240°, and 360° - in the treatment of Primary Congenital Glaucoma (PCG). The study incorporates both retro…
Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New cochlear implants aim to sharpen hearing for adults
Disease control Not yet recruitingThe aim of this clinical investigation is to demonstrate the performance, clinical benefit and safety of commercial cochlear implant systems. Speech performance and subjective hearing results, and comparison with cochlear implant results available in literature, is intended to de…
Sponsor: Cochlear • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New hope for arthritis sufferers: experimental drug GenSci120 enters Mid-Stage trial
Disease control Recruiting nowThis is a multicenter, randomized, double-blind, parallel, placebo- and active comparator- controlled clinical study conducted in patients with moderately to severely active RA and an inadequate response to at least one DMARD, designed to assess the efficacy and safety of GenSci1…
Phase: PHASE2 • Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New hope for rare cholesterol disease: can evinacumab shrink dangerous plaque?
Disease control Recruiting nowThis observational, multicenter, retrospective and prospective study aims to evaluate the impact of intensified lipid-lowering therapy including Evinacumab on coronary atherosclerotic plaque burden in patients with Homozygous Familial Hypercholesterolemia (HoFH). HoFH is a rare …
Sponsor: Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi) • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Heart-Safe chemo? new study tests vasodilators to prevent chest pain in cancer patients
Disease control Recruiting nowThis phase I/II trial compares the effect of drugs that causes widening of blood vessels as a result of smooth muscle relaxation (vasodilator therapy) with isosorbide mononitrate, diltiazem or placebo to reduce vasotoxicity in patients with gastrointestinal cancer receiving fluor…
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New depression pill JS1-1-01 enters key trials
Symptom relief Not yet recruitingThe purpose of this study is to evaluate the Effectiveness and Safety of JS1-1-01 Tablet in Patients With Moderate to Severe Depression
Phase: PHASE2, PHASE3 • Sponsor: Tasly Pharmaceutical Group Co., Ltd • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
New stent aims to tackle tough heart blockages
Disease control Not yet recruitingThe objective is to evaluate the efficacy and safety of the Inspiron™ EVO drug-eluting stent in complex coronary lesions in a real-world population. Patients with symptomatic ischemic heart disease due to lesions in native coronary arteries and restenotic lesions will be treated …
Sponsor: Scitech Produtos Medicos SA • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Weight-Loss drug semaglutide tested as cannabis craving cure
Disease control Recruiting nowThe HASHTAG Study is investigating whether the medicine semaglutide can help adults with cannabis use disorder (CUD) reduce their cannabis use. Participants will be randomly assigned to receive either semaglutide or a placebo. The first 50 participants will have functional brain …
Phase: PHASE2 • Sponsor: Anders Fink-Jensen, MD, DMSci • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Can starting multiple kidney drugs at once slow Diabetes-Related kidney damage?
Disease control Not yet recruitingThe goal of this clinical trial is to learn if starting four kidney disease medicines quickly and together (a rapid treatment approach) is safe and works well in people with type 2 diabetes and chronic kidney disease. The main questions it aims to answer are: * Is it safe to st…
Phase: PHASE4 • Sponsor: Baylor Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New drug ES014 targets desmoid tumors in Mid-Stage trial
Disease control Recruiting nowThis is an open-label, multicenter, single-arm phase 2 clinical study designed to evaluate the efficacy, safety, tolerability, patient-reported outcomes (PROs), pharmacokinetics (PK), anti-drug antibody (ADA) and pharmacodynamics (PD) of ES014 in adult desmoid tumor patients.
Phase: PHASE2 • Sponsor: Elpiscience (Suzhou) Biopharma, Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Brain zaps may curb Self-Harm in depressed teens
Symptom relief Recruiting nowTemporal Interference Stimulation (TIS) has been successfully used to help patients with depression. However, its role in alleviating self injuries remained uncertain. This trial will compare the effectiveness of TIS to a placebo control on non-suicidal self injury (NSSI) in pati…
Phase: NA • Sponsor: The Second Hospital of Anhui Medical University • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
Nanobody-Powered CAR-Ts take on tough lymphoma
Disease control Not yet recruitingThis is a single arm study to evaluate the safety and efficacy of Nanobody-Based CD19/CD20 Tandem Dual CAR-T-cell therapy for Relapsed/Refractory B-Cell Lymphoma
Phase: EARLY_PHASE1 • Sponsor: Affiliated Hospital to Academy of Military Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Could an HIV drug tame brain inflammation in Alzheimer's?
Disease control Recruiting nowThe present study will administer the drug leronlimab to 20 participants who are above 50 years old with Alzheimer's disease (AD) or mild cognitive impairment (MCI) due to AD. While leronlimab is considered safe in other diseases like Human Immunodeficiency Virus (HIV) and certai…
Phase: PHASE2 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Could a vaginal suppository clear High-Risk HPV?
Disease control Recruiting nowThe goal of this clinical trial is to learn if an investigational vaginal suppository therapy works to treat low-grade cervical lesions (ASC-US and LSIL) associated with high-risk human papillomavirus (hr-HPV) infection in women. It will also learn about the safety and tolerabili…
Phase: PHASE2 • Sponsor: Amplexd Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New drug cocktail aims to beat tough infection in HIV patients
Disease control Not yet recruitingBackground: Disseminated Mycobacterium avium complex (MAC) infection remains a serious opportunistic infection in patients with advanced HIV infection, particularly among those with severe immunosuppression. Despite the widespread use of antiretroviral therapy (ART), disseminate…
Phase: NA • Sponsor: Shanghai Public Health Clinical Center • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Ovarian puncture may boost egg count in women with low reserve
Disease control Not yet recruitingA multicenter, prospective, randomized controlled clinical trial. The target population consists of patients undergoing IVF/ICSI artificial reproduction who plan to undergo ovarian stimulation and embryo retrieval (DOR) within 4 months. A stratified block randomization method was…
Phase: NA • Sponsor: First Affiliated Hospital of Guangxi Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New injection aims to revive immune system in HIV patients
Disease control Not yet recruitingThe Phase Ib clinical trial is an add-on study based on combination antiretroviral therapy (cART). It adopts a multicenter, randomized, double-blind, placebo-controlled, multiple-dose design to evaluate the safety and efficacy of multiple intramuscular injections of JL18008 added…
Phase: PHASE1, PHASE2 • Sponsor: Jecho Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New injection shows promise for Hard-to-Treat lung condition
Disease control Recruiting nowThis is a Phase Ib/IIa clinical study of IMC-003 treatment in pulmonary arterial hypertension (PAH) patients receiving background therapy
Phase: PHASE1, PHASE2 • Sponsor: ImmuneCare Biopharmaceuticals (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Infrared eye on ear infections: new device aims to see fluid that white light misses
Diagnosis Recruiting nowThe aim of this study is to provide preliminary data to support future studies to demonstrate that the short wave infrared (SWIR) otoscope is a better diagnostic tool than a white light otoscope for diagnosing middle ear infections (otitis media). Patients who are having a tympan…
Phase: NA • Sponsor: Stanford University • Aim: Diagnosis
Last updated Jul 26, 2026 00:00 UTC
-
New hope for stubborn high cholesterol: experimental drug SHR-1918 enters trials
Disease control Recruiting nowThe purpose of the study is to evaluate the efficacy and safety of SHR-1918 in patients with hypercholesterolemia with inadequate lipid control on statins plus PCSK9 inhibitors. The efficacy and safety of SHR-1918 will be evaluated after 12-weeks and 24-weeks treatment.
Phase: PHASE2, PHASE3 • Sponsor: Beijing Suncadia Pharmaceuticals Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC